Chinese Biotech Isn’t What You Think – Matt Krisiloff
More founders and investors debating China’s rise should go and visit In June, I spent two weeks in Shanghai, Shenzhen, and Hong Kong meeting dozens of biotech founders, scientists, professor…
More founders and investors debating China’s rise should go and visit In June, I spent two weeks in Shanghai, Shenzhen, and Hong Kong meeting dozens of biotech founders, scientists, professors, investors, CEOs, and clinicians. I went in with a mindset that biotech in the U.S. was in serious trouble. I left thinking it didn’t surpass the best of what America has to offer, and overall contained a lot of unappreciated nuances. Undoubtedly, China’s ability to move experimental therapies into patients quickly and cheaply is a real structural advantage. But I was also surprised to find how…
saved by
related reading
- Notes from China, Q3 2026milan.cvitkovic.net
- Bohan (@loubohan) on Xx.com
- Having a very Chinese timetheombl.substack.com
- Tech vs Biotech - Celine Haliouacelinehh.com
- Observations from BIOCHINA2025sepiabio.substack.com
- Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
- America Against China Against America - by Jasmine Sunjasmi.news
- Will all our drugs come from China? | Alex’s blogatelfo.github.io
- China Travel Blog - by Charles Yang - Rough Draftscharlesyang.substack.com
- Why the Canadian Tech Scene Doesn’t Work – Alex Danco's Newsletteralexdanco.com
- Notes on Chinadwarkeshpatel.com
- A Reading Guide to Chinese Biotechnikomc.com